Drug Shortage Report for RAN-MONTELUKAST

Last updated on 2019-02-01 History
Report ID 11133
Drug Identification Number 02402807
Brand name RAN-MONTELUKAST
Common or Proper name RAN-MONTELUKAST
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Market Status CANCELLED POST MARKET
Active Ingredient(s) MONTELUKAST
Strength(s) 5MG
Dosage form(s) TABLET (CHEWABLE)
Route of administration ORAL
Packaging size 30
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2016-10-01
Actual start date 2016-10-01
Estimated end date Unknown
Actual end date 2017-11-24
Shortage status Resolved
Updated date 2019-02-01
Company comments Discontinued
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2019-02-01 French Compare
v11 2019-02-01 English Compare
v10 2017-11-22 French Compare
v9 2017-11-22 English Compare
v8 2017-10-27 French Compare
v7 2017-10-27 English Compare
v6 2017-09-26 French Compare
v5 2017-09-26 English Compare
v4 2017-09-12 French Compare
v3 2017-09-12 English Compare
v2 2017-05-24 French Compare
v1 2017-05-24 English Compare

Showing 1 to 12 of 12